scispace - formally typeset
A

Anna-Lisa Sorg

Researcher at Ludwig Maximilian University of Munich

Publications -  18
Citations -  161

Anna-Lisa Sorg is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 11 publications receiving 28 citations.

Papers
More filters
Journal ArticleDOI

Risk factors for perinatal arterial ischaemic stroke: a large case–control study

TL;DR: To identify maternal, obstetric, and neonatal risk factors related to perinatal arterial ischaemic stroke (PAIS) diagnosed within 28 days after birth and to understand the underlying pathophysiology.
Journal ArticleDOI

Arterial ischemic stroke in infants, children, and adolescents: results of a Germany-wide surveillance study 2015-2017

TL;DR: Investigation of incidence, age-dependent clinical presentation, and risk factors and the medical care situation in Germany found that stroke incidence showed peaks in infants, children’< 2 years of age, and adolescents (12–18 years), with a significant male predominance observed in adolescents only.
Journal ArticleDOI

Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany

TL;DR: In this article , the authors combine data from three data sources -a national seroprevalence study (the SARS-CoV-2 KIDS study), the nationwide, state-based reporting system for PCR-confirmed SARS and CoV2 infections in Germany, and a nationwide registry on children and adolescents hospitalized with either SARS or pediatric inflammatory multisystem syndrome (PIMS-TS, also known as MIS-C) to provide estimates on the risk of hospitalization for COVID-19-related treatment, intensive care admission, and death due to COVID19 and PIMs-TS in children.
Posted ContentDOI

Risk of Hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany

TL;DR: In this article, the authors combine data from three sources -a national seroprevalence study (the SARS-CoV-2 KIDS study), the German statutory notification system and a nationwide registry on children and adolescents hospitalized with either SARS CoV2 or Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) in order to provide reliable estimates on childrens hospitalization, intensive care admission and death due to COVID-19 and PIMs-TS.